The best pharma bets, according to this CIO who manages investments worth Rs 500 crore
Ravi Dharamshi is CIO of Valuequest Investment Advisors and manages investments of around Rs 500 crore. In his role, Dharamshi is sector agnostic but has a long history with pharma. He began investing in pharma and healthcare stocks back in 2002 and worked previously with Rare Enterprises. Some of his key bets in pharma have included Lupin, Glenmark, Natco and Divi’s. Tune into Dharamshi’s journey of investing in pharma and healthcare stocks, how the landscape has changed and his take on top industry trends and stocks. Happy listening!